BioForce Nanosciences
We develop and commercializes nanotech instruments, consumables, and applications for the life sciences.
We develop and commercializes nanotech instruments, consumables, and applications for the life sciences.
BioForce Nanosciences is a leading developer and commercializer of nanotech instruments, consumables, and applications for the life sciences. Established in 1999, the company has garnered recognition for its flagship instrument platform, the Nano eNabler™ system. This molecular printer has the remarkable ability to deliver liquids to surfaces in droplets ten billion times smaller than a drop of blood, offering practical solutions to ultra-miniaturization challenges and opening new avenues for the commercialization of nanotechnology.
With a strong focus on the biotechnology industry, BioForce Nanosciences has made significant strides in diverse applications such as creating biosensors and studying cell biology at the single-cell level. Moreover, the company's technology has been instrumental in printing proteins to guide neural cell growth, studying stem cell differentiation, and bio-functionalizing microfluidic devices. These innovations have demonstrated the potential for impactful contributions to the field of life sciences.
In November 2002, the company secured a $2.00M Venture Round investment from Societe Generale Asset Management, signifying external validation and support for their pioneering work in nanotechnology. This injection of capital likely played a crucial role in advancing their research and accelerating their journey towards commercial success.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $2.00M | 1 | Societe Generale Asset Management | 15 Nov 2002 |
No recent news or press coverage available for BioForce Nanosciences.
We care about your data, and we'd love to use cookies make your experience better.